Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1996 | 3 |
1998 | 2 |
1999 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group.
AIDS Res Hum Retroviruses. 1996 May 20;12(8):683-93. doi: 10.1089/aid.1996.12.683.
AIDS Res Hum Retroviruses. 1996.
PMID: 8744579
Clinical Trial.
HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
Gorse GJ, Corey L, Patel GB, Mandava M, Hsieh RH, Matthews TJ, Walker MC, McElrath MJ, Berman PW, Eibl MM, Belshe RB.
Gorse GJ, et al.
AIDS Res Hum Retroviruses. 1999 Jan 20;15(2):115-32. doi: 10.1089/088922299311547.
AIDS Res Hum Retroviruses. 1999.
PMID: 10029244
Clinical Trial.
Item in Clipboard
Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
Gorse GJ, McElrath MJ, Matthews TJ, Hsieh RH, Belshe RB, Corey L, Frey SE, Kennedy DJ, Walker MC, Eibl MM.
Gorse GJ, et al.
Vaccine. 1998 Mar;16(5):493-506. doi: 10.1016/s0264-410x(97)80003-5.
Vaccine. 1998.
PMID: 9491504
Free article.
Clinical Trial.
Item in Clipboard
Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.
Gorse GJ, Patel GB, Newman FK, Belshe RB, Berman PW, Gregory TJ, Matthews TJ.
Gorse GJ, et al.
Clin Diagn Lab Immunol. 1996 Jul;3(4):378-86. doi: 10.1128/cdli.3.4.378-386.1996.
Clin Diagn Lab Immunol. 1996.
PMID: 8807200
Free PMC article.
Clinical Trial.
Item in Clipboard
Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage.
Montefiori DC, Collman RG, Fouts TR, Zhou JY, Bilska M, Hoxie JA, Moore JP, Bolognesi DP.
Montefiori DC, et al.
J Virol. 1998 Mar;72(3):1886-93. doi: 10.1128/JVI.72.3.1886-1893.1998.
J Virol. 1998.
PMID: 9499040
Free PMC article.
Item in Clipboard
Complement-activating antibodies in sera from infected individuals and vaccinated volunteers that target human immunodeficiency virus type 1 to complement receptor type 1 (CR1, CD35).
Zhou J, Montefiori DC.
Zhou J, et al.
Virology. 1996 Dec 1;226(1):13-21. doi: 10.1006/viro.1996.0623.
Virology. 1996.
PMID: 8941318
Free article.
Item in Clipboard
Cite
Cite